Primary Care Clinics in Holdrege, NE Accepting Medicare
7 Primary Care Clinics found. Showing 1 - 7
 Bilka Chiropractic, Llc Clinic/Center Medicare: Medicare Enrolled Practice Location: 701 4th Ave. Ste. 3, Holdrege, NE 68946 Phone: 308-995-2355 Fax: 308-995-2355 |
Family Medical Specialties Family Medicine Medicare: Medicare Enrolled Practice Location: 516 W 14th Ave, Ste 100, Holdrege, NE 68949 Phone: 308-995-4431 Fax: 308-995-3247 |
Phelps Memorial Health Center Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1315 Tibbals St, Holdrege, NE 68949 Phone: 308-995-6111 |
Holdrege Medical Clinic, P.c. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 516 W 14th Ave Ste 100, Holdrege, NE 68949 Phone: 308-995-4431 |
High Plains Clinic, Llc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1315 Tibbals St, Holdrege, NE 68949 Phone: 308-995-6111 Fax: 308-995-4868 |
Two Rivers Public Health Department Clinic/Center - Public Health, State or Local Medicare: Medicare Enrolled Practice Location: 701 4th Ave, Suite 1, Holdrege, NE 68949 Phone: 308-995-4778 Fax: 308-995-4073 |
Phelps Medical Group Family Medicine Medicare: Medicare Enrolled Practice Location: 1315 Tibbals St, Holdrege, NE 68949 Phone: 308-995-6111 |
News Archive
If you thought getting mugged was more likely than a stroke - wrong again!
A new survey suggests that the risk of having a stroke is greatly underestimated by most people in the UK.
Study into spread of sexually transmitted infection in ladybirds
A study at the University of Liverpool into the spread of sexually transmitted infection in ladybirds has shown that disease risk to large populations cannot be predicted without a full understanding of the disease dynamics at small geographical scale.
MRI research may lead to new methods for diagnosing ADHD and other mental health disorders
Oregon Health & Science University researchers, along with scientists at Washington University in St. Louis, are uncovering new information about the mind by studying the brain while it is at rest. It is believed this research will one day provide new tools for diagnosing mental health disorders and monitoring the progress of treatments.
Alkermes initiates multidose Phase 1 clinical study of ALKS 37 for OIC
Alkermes, Inc. today announced the initiation of a multidose phase 1 clinical study of ALKS 37, an orally active, peripherally-restricted opioid antagonist with potential to block the effects of opioid agonists on gastrointestinal motility, commonly referred to as opioid-induced constipation (OIC). The randomized, double-blind, placebo-controlled, repeat-dose study will assess the safety, tolerability and pharmacokinetics of daily oral administration of two dose levels of ALKS 37 for a seven day period in approximately 24 healthy volunteers.
› Verified 5 days ago